Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Glucose Transporter Type 1 Deficiency Syndrome

Juan Pascual – Glut1 Deficiency Syndrome Juan Pascual – Glucose Transporter Type 1 Deficiency Syndrome

Ketonemia Through Menstrual Cycle Brain Metabolism Observed at 7 Tesla Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) Treatment Development of Triheptanoin (G1D) The Glucose Transporter Type I Deficiency (G1D) Registry Evaluation of Ketoflo Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D Evaluation of Keyo in Children With Epilepsy Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome Evaluation of Krio in Children and Adults With Epilepsy Post Study Continuation of C7 for G1D Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS) Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Sodium Lactate Infusion in GLUT1DS Patients Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)